Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy

Endocrine

Volumn 41, Issue 2, 2012, Pages 248-255

  Zhang, Chu ^a   Zhang, Xianfeng ^a   Ma, Lizhen ^a   Peng, Fengying ^a   Huang, Jiao ^a   Han, Hui ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Adipogenesis; Graves' ophthalmopathy; PPARc; Thalidomide; TSHR

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THALIDOMIDE; THYROTROPIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENDOCRINE OPHTHALMOPATHY; FAT CONTENT; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORBIT; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84862777022     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9600-8     Document Type: Article

References (25)

1. L. Bartalena, A. Pinchera, C. Marcocci, Management of Graves' ophthalmopathy: reality and perspectives. Endocr. Rev. 21(2), 168-199 (2000) (Pubitemid 32275594)
2. T. Cawood, P. Moriarty, D. O'Shea, Recent developments in thyroid eye disease. BMJ 329(7462), 385-390 (2004). doi:10.1136/bmj.329.7462.385 (Pubitemid 39099747)
3. R.S. Bahn, A.E. Heufelder, Pathogenesis of Graves' ophthalmopathy. N. Engl. J. Med. 329(20), 1468-1475 (1993). doi:10.1056/NEJM199311113292007 (Pubitemid 23335894)
4. T.K. Khoo, R.S. Bahn, Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies. Thyroid 17(10), 1013-1018 (2007). doi:10.1089/thy.2007.0185 (Pubitemid 350071598)
5. G. Forbes, C.A. Gorman, M.D. Brennan, D.G. Gehring, D.M. Ilstrup, F.t. Earnest, Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle. Am. J. Neuroradiol. 7(4), 651-656 (1986) (Pubitemid 16099150)
6. R.G. Peyster, F. Ginsberg, J.H. Silber, L.P. Adler, Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis. Am. J. Roentgenol. 146(3), 459-464 (1986) (Pubitemid 16106587)
7. Y. Hiromatsu, D. Yang, T. Bednarczuk, I. Miyake, K. Nonaka, Y. Inoue, Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy. J. Clin. Endocrinol. Metab. 85(3), 1194-1199 (2000) (Pubitemid 32269371)
8. R.W. Valyasevi, D.A. Harteneck, C.M. Dutton, R.S. Bahn, Stimulation of adipogenesis, peroxisome proliferator-activated receptorgamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. J. Clin. Endocrinol. Metab. 87(5), 2352-2358 (2002) (Pubitemid 34521530)
9. S. Kumar, M.J. Coenen, P.E. Scherer, R.S. Bahn, Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 89(2), 930-935 (2004) (Pubitemid 38269913)
10. C. Marcocci, L. Bartalena, M.L. Tanda, L. Manetti, E. Dell'Unto, R. Rocchi, G. Barbesino, B. Mazzi, M.P. Bartolomei, P. Lepri, F. Cartei, M. Nardi, A. Pinchera, Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J. Clin. Endocrinol. Metab. 86(8), 3562-3567 (2001) (Pubitemid 32755944)
11. R.S. Bahn, C.M. Dutton, W. Joba, A.E. Heufelder, Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin. Thyroid 8(2), 193-196 (1998) (Pubitemid 28103609)
12. O. Gutierrez-Rodriguez, P. Starusta-Bacal, O. Gutierrez-Montes, Treatment of refractory rheumatoid arthritis-the thalidomide experience. J. Rheumatol. 16(2), 158-163 (1989) (Pubitemid 19085218)
13. M. Carlesimo, S. Giustini, A. Rossi, P. Bonaccorsi, S. Calvieri, Treatment of cutaneous and pulmonary sarcoidosis with thalidomide. J Am Acad Dermatol 32(5 Pt 2), 866-869 (1995)
14. N.M. Moutsopoulos, N. Angelov, V. Sankar, R.A. Leakan, S. Pillemer, S.M. Wahl, Immunological consequences of thalidomide treatment in Sjogren's syndrome. Ann. Rheum. Dis. 65(1), 112-114 (2006). doi:10.1136/ard.2005.038406 (Pubitemid 41815650)
15. A.L. Holm, K.E. Bowers, T.O. McMeekin, A.A. Gaspari, Chronic cutaneous lupus erythematosus treated with thalidomide. Arch. Dermatol. 129(12), 1548-1550 (1993) (Pubitemid 23357905)
16. A.L. Moreira, E.P. Sampaio, A. Zmuidzinas, P. Frindt, K.A. Smith, G. Kaplan, Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med. 177(6), 1675-1680 (1993) (Pubitemid 23146134)
17. J.N. Gordon, P.M. Goggin, Thalidomide and its derivatives: emerging from the wilderness. Postgrad. Med. J. 79(929), 127-132 (2003) (Pubitemid 36520751)
18. R.S. Bahn, Graves' ophthalmopathy. N. Engl. J. Med. 362(8), 726-738 (2010). doi:10.1056/NEJMra0905750
19. R.W. Valyasevi, S.C. Jyonouchi, C.M. Dutton, N. Munsakul, R.S. Bahn, Effect of tumor necrosis factor-alpha, interferon-gamma, and transforming growth factor-beta on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts. J. Clin. Endocrinol. Metab. 86(2), 903-908 (2001) (Pubitemid 32207513)
20. B. Zhang, J. Berger, E. Hu, D. Szalkowski, S. White-Carrington, B.M. Spiegelman, D.E. Moller, Negative regulation of peroxisome proliferator- activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Mol. Endocrinol. 10(11), 1457-1466 (1996) (Pubitemid 26423234)
21. M.I. Lefterova, M.A. Lazar, New developments in adipogenesis. Trends Endocrinol Metab 20(3), 107-114 (2009)
22. H.R. Gockel, A. Lugering, J. Heidemann, M. Schmidt, W. Domschke, T. Kucharzik, N. Lugering, Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway. J. Immunol. 172(8), 5103-5109 (2004) (Pubitemid 38456439)
23. J. Knobloch, I. Schmitz, K. Gotz, K. Schulze-Osthoff, U. Ruther, Thalidomide induces limb anomalies by PTEN stabilization, Akt suppression, and stimulation of caspase-dependent cell death. Mol. Cell. Biol. 28(2), 529-538 (2008)
24. S. Tsui, V. Naik, N. Hoa, C.J. Hwang, N.F. Afifiyan, A. Sinha Hikim, A.G. Gianoukakis, R.S. Douglas, T.J. Smith, Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. J. Immunol. 181(6), 4397-4405 (2008). doi:181/6/4397
25. M. Lu, R.Y. Lin, TSH stimulates adipogenesis in mouse embryonic stem cells. J. Endocrinol. 196(1), 159-169 (2008). doi: 10.1677/JOE-07-0452 (Pubitemid 351234581)